Structure Therapeutics Inc
NASDAQ:GPCR
Balance Sheet
Balance Sheet Decomposition
Structure Therapeutics Inc
Structure Therapeutics Inc
Balance Sheet
Structure Therapeutics Inc
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
16
|
105
|
26
|
130
|
170
|
|
| Cash Equivalents |
16
|
105
|
26
|
130
|
170
|
|
| Short-Term Investments |
21
|
2
|
65
|
338
|
714
|
|
| Other Current Assets |
1
|
2
|
2
|
6
|
8
|
|
| Total Current Assets |
38
|
109
|
93
|
474
|
891
|
|
| PP&E Net |
0
|
2
|
1
|
8
|
7
|
|
| PP&E Gross |
0
|
2
|
1
|
8
|
7
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
2
|
|
| Other Long-Term Assets |
0
|
0
|
3
|
0
|
5
|
|
| Total Assets |
39
N/A
|
111
+187%
|
98
-12%
|
482
+393%
|
903
+87%
|
|
| Liabilities | ||||||
| Accounts Payable |
2
|
3
|
6
|
5
|
8
|
|
| Accrued Liabilities |
1
|
5
|
6
|
19
|
24
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
1
|
4
|
|
| Total Current Liabilities |
3
|
9
|
13
|
25
|
36
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
4
|
2
|
|
| Total Liabilities |
3
N/A
|
9
+182%
|
13
+46%
|
29
+123%
|
38
+32%
|
|
| Equity | ||||||
| Common Stock |
58
|
167
|
200
|
0
|
0
|
|
| Retained Earnings |
23
|
65
|
117
|
207
|
329
|
|
| Additional Paid In Capital |
0
|
0
|
2
|
659
|
1 193
|
|
| Other Equity |
0
|
0
|
0
|
1
|
1
|
|
| Total Equity |
36
N/A
|
102
+188%
|
85
-17%
|
453
+434%
|
865
+91%
|
|
| Total Liabilities & Equity |
39
N/A
|
111
+187%
|
98
-12%
|
482
+393%
|
903
+87%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
110
|
110
|
110
|
139
|
172
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
|